Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.440
-0.030 (-2.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $32.27 million as of April 28, 2026. Its market cap has increased by 18.61% in one year.
Market Cap
32.27M
Enterprise Value
-26.17M
1-Year Change
18.61%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $32.27M, a decrease of -90.93%. That is a compound annual growth rate of -68.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 32.27M | 20.12% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 34.36M |
| CervoMed | 34.26M |
| Pluri | 33.87M |
| Werewolf Therapeutics | 33.83M |
| NextCure | 33.50M |
| Skye Bioscience | 33.06M |
| Grace Therapeutics | 32.73M |
| Daré Bioscience | 32.18M |